Q3 2023 Holdings
Filed 2023-11-14 | 83 holdings | $549.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds LTD(TEVA)Call | SPONSORED ADS | 881624209 | $51.1M | 5,013,800 | 9.3% |
| Invesco QQQ TRPut | PUT | 46090E953 | $48.9M | 136,500 | 8.9% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $26.8M | 499,515 | 4.9% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $19.3M | 285,060 | 3.5% |
| Nice LTD(NSY)Call | SPONSORED ADR | 653656108 | $17.9M | 105,000 | 3.3% |
| Enphase Energy Inc | NOTE 3/0 | 29355AAK3 | $17.3M | 20,900,000 | 3.2% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $14.8M | 94,831 | 2.7% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $12.7M | 123,600 | 2.3% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $12.1M | 95,300 | 2.2% |
| Tower Semiconductor LTD(TSEM) | SHS NEW | M87915274 | $11.5M | 469,574 | 2.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $11.2M | 773,061 | 2.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $10.9M | 34,442 | 2.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $9.2M | 259,135 | 1.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $9.1M | 345,537 | 1.7% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $8.5M | 93,080 | 1.5% |
| Praxis Precision Medicines I | COM | 74006W108 | $8.3M | 4,850,317 | 1.5% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $7.6M | 14,190 | 1.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $7.4M | 50,867 | 1.4% |
| Springworks Therapeutics Inc | COM | 85205L107 | $7.4M | 319,911 | 1.3% |
| Immatics N.v(IMTX) | SHS | N44445109 | $7.1M | 617,173 | 1.3% |
| SHL Telemedicine LTD | SPONSORED ADS | 78423T200 | $7.0M | 632,256 | 1.3% |
| Solaredge Technologies Inc(SEDG)Call | COM | 83417M104 | $6.9M | 53,500 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.9M | 233,933 | 1.3% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $6.9M | 46,000 | 1.2% |
| Palo Alto Networks Inc(PANW) | COM | 697435105 | $6.7M | 28,759 | 1.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $6.6M | 25,846 | 1.2% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $6.5M | 530,000 | 1.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $6.4M | 703,287 | 1.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $6.4M | 36,101 | 1.2% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $6.4M | 37,482 | 1.2% |
| Point Biopharma Global Inc | COM | 730541109 | $6.4M | 952,642 | 1.2% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $6.1M | 600,000 | 1.1% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $6.1M | 60,000 | 1.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.1M | 50,000 | 1.1% |
| Merus N V | COM | N5749R100 | $6.0M | 253,333 | 1.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $5.2M | 111,398 | 1.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $5.2M | 1,234,907 | 0.9% |
| Advanced Micro Devices Inc(AMD) | COM | 007903107 | $5.0M | 48,320 | 0.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $5.0M | 180,000 | 0.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.9M | 319,301 | 0.9% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $4.9M | 218,459 | 0.9% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $4.7M | 256,371 | 0.9% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $4.6M | 15,220 | 0.8% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $4.4M | 1,531,497 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.3M | 580,599 | 0.8% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.3M | 455,400 | 0.8% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $4.3M | 209,040 | 0.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $4.1M | 420,000 | 0.7% |
| Jasper Therapeutics Inc | COM | 471871103 | $4.0M | 5,687,134 | 0.7% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $3.7M | 1,834,042 | 0.7% |